[Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma]
Katsaros D, Fracchioli S, Arts HJ, de Vries EG, Danese S, Richiardi G, Arisio R, Gordini G, Van der Zee AG, Suurmeijer AJ, Massobrio M.
Minerva Ginecol. 1999 Dec;51(12):463-70. Italian. PMID: 10767994 [PubMed - indexed for MEDLINE]Related articles